Nov 9 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP REPORTS IMPROVED AND STATISTICALLY SIGNIFICANT SURVIVAL BENEFIT FOR THREE KEY PATIENT GROUPS IN FINAL PHASE IIB AIPAC STUDY RESULTS IN METASTATIC BREAST CANCER
Nov 9 (Reuters) - Immutep Ltd (IMM) : IMMUTEP REPORTS IMPROVED...
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $559.2M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $964.8K | 2.532M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 79405 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 36041 | 21 |
View Market Depth
| Last trade - 12.38pm 28/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |